Argen-X (LSE:0QW0) — Market Cap & Net Worth
Market Cap & Net Worth: Argen-X (0QW0)
Argen-X (LSE:0QW0) has a market capitalization of $13.37 Billion (€11.44 Billion) as of September 17, 2026. Listed on the LSE stock exchange, this UK-based company holds position #1782 globally and #7 in its home market, demonstrating a -0.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Argen-X's stock price €863.30 by its total outstanding shares 32450800 (32.45 Million). Also see how large is Argen-X's balance sheet for a full breakdown of the balance sheet.
Argen-X Market Cap History: 2015 to 2026
Argen-X's market capitalization history from 2015 to 2026. Data shows growth from $352.83 Million to $32.75 Billion (52.12% CAGR). Also see how efficiently does Argen-X generate cash for how efficiently the company converts equity into cash flow.
Argen-X Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Argen-X's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Argen-X stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
10.44x
Argen-X's market cap is 10.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
28.24x
Argen-X's market cap is 28.24 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $352.83 Million | $7.49 Million | -$16.74 Million | 47.08x | N/A |
| 2016 | $504.58 Million | $15.47 Million | -$22.48 Million | 32.61x | N/A |
| 2017 | $1.86 Billion | $43.69 Million | -$33.68 Million | 42.57x | N/A |
| 2018 | $3.23 Billion | $24.57 Million | -$76.23 Million | 131.38x | N/A |
| 2019 | $5.47 Billion | $78.46 Million | -$181.21 Million | 69.68x | N/A |
| 2020 | $9.16 Billion | $41.24 Million | -$608.46 Million | 222.06x | N/A |
| 2021 | $11.96 Billion | $497.28 Million | -$408.26 Million | 24.06x | N/A |
| 2022 | $13.32 Billion | $410.75 Million | -$709.59 Million | 32.43x | N/A |
| 2023 | $13.10 Billion | $1.23 Billion | -$295.05 Million | 10.68x | N/A |
| 2024 | $22.71 Billion | $2.17 Billion | $804.13 Million | 10.44x | 28.24x |
Competitor Companies of 0QW0 by Market Capitalization
Companies near Argen-X in the global market cap rankings as of September 17, 2026. Review 0QW0 intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Argen-X by market ranking:
- Fabrinet (NYSE:FN): Ranked #1773 globally with a market cap of $13.43 Billion USD.
- XCMG Construction Machinery Co Ltd (SHE:000425): Ranked #1774 globally with a market cap of $13.43 Billion USD ( CN¥91.76 Billion CNY).
- Bajaj Holdings & Investment Limited (NSE:BAJAJHLDNG): Ranked #1783 globally with a market cap of $13.36 Billion USD ( Rs1.24 Trillion INR).
- Juniper Networks Inc (NYSE:JNPR): Ranked #1784 globally with a market cap of $13.36 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1773 | Fabrinet | NYSE:FN | $13.43 Billion | $374.91 |
| #1774 | XCMG Construction Machinery Co Ltd | SHE:000425 | $13.43 Billion | CN¥7.81 |
| #1783 | Bajaj Holdings & Investment Limited | NSE:BAJAJHLDNG | $13.36 Billion | Rs11100.00 |
| #1784 | Juniper Networks Inc | NYSE:JNPR | $13.36 Billion | $39.95 |
Argen-X Historical Marketcap From 2015 to 2026
Between 2015 and today, Argen-X's market cap moved from $352.83 Million to $ 32.75 Billion, with a yearly change of 52.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €32.75 Billion | +20.69% |
| 2025 | €27.14 Billion | +19.52% |
| 2024 | €22.71 Billion | +73.30% |
| 2023 | €13.10 Billion | -1.65% |
| 2022 | €13.32 Billion | +11.37% |
| 2021 | €11.96 Billion | +30.62% |
| 2020 | €9.16 Billion | +67.52% |
| 2019 | €5.47 Billion | +69.33% |
| 2018 | €3.23 Billion | +73.60% |
| 2017 | €1.86 Billion | +268.57% |
| 2016 | €504.58 Million | +43.01% |
| 2015 | €352.83 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Argen-X was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.37 Billion USD |
| MoneyControl | $13.37 Billion USD |
| MarketWatch | $13.37 Billion USD |
| marketcap.company | $13.37 Billion USD |
| Reuters | $13.37 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Argen-X
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgarti… Read more